[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Page 42001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15535]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


National Institutes of Health; Statement of Delegation of 
Authority

    Notice is hereby given that I have delegated to the Director, 
National Institutes of Health, the authority under Part B, Title IV, 
section 409I(a) and (b) of the Public Health Service (PHS) Act, as 
amended by Public Law 107-109 (Best Pharmaceuticals for Children Act), 
to (1) award contracts to entities that have the expertise to conduct 
pediatric clinical trials, to enable the entities to conduct pediatric 
studies concerning one or more of the drugs identified in the list 
described in subsection (a) of section 409I of the PHS Act, as amended, 
and (2) to develop and publish the list of drugs described in 
subsection (a) of section 409I of the PHS Act, as amended.
    This delegation shall be exercised in accordance with the 
Department's applicable policies, procedures, guidelines and 
regulations. In addition, I ratify and affirm any actions taken by the 
Director, National Institutes of Health, or subordinates which involved 
the exercise of the authorities delegated herein prior to the effective 
date of this delegation.
    This delegation is effective upon date of signature.

    Dated: June 12, 2002.
Tommy G. Thompson,
Secretary.
[FR Doc. 02-15535 Filed 6-14-02; 8:45 am]
BILLING CODE 4140-01-M